Patent details

EP1187612 Title: USE OF RILUZOLE FOR THE TREATMENT OF MULTIPLE SCLEROSIS

Basic Information

Publication number:
EP1187612
PCT Application Number:
PCT/IB/2000/000933
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009390071
PCT Publication Number:
WO/2000/074676
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF RILUZOLE FOR THE TREATMENT OF MULTIPLE SCLEROSIS
French Title of Invention:
UTILISATION DE RILUZOLE POUR LE TRAITEMENT DE LA SCLEROSE EN PLAQUES
German Title of Invention:
VERWENDUNG VON RILUZOL ZUR BEHANDLUNG MULTIPLER SKLEROSE
SPC Number:

Dates

Filing date:
02/06/2000
Grant date:
26/01/2005
EP Publication Date:
26/01/2005
PCT Publication Date:
14/12/2000
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/03/2002
EP B1 Publication Date:
26/01/2005
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
02/06/2019
Expiration date:
02/06/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/06/2000
 
 

Name:
VERENIGING VOOR CHRISTELIJK WETENSCHAPPELIJK ONDER
Address:
De Boelelaan 1105, NL-1081 HV Amsterdam, Netherlands (NL)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
06/04/2005
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
POLMAN Chris
Address:
Netherlands (NL)

Priority

1

Priority Number:
99201788
Priority Date:
04/06/1999
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
174328 P
Priority Date:
04/01/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/425;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
29/06/2018
Last Annual Fee Paid Number:
19
Last Annual Fee Paid Amount:
281 Euro
Payer:
ENVOY INTERNATIONAL LIMITED
Filing date Document type Number of pages